Citrini Fails to Make AI Drug

Investment firm Citrini partnered with Anthropic to test if Claude could create scorpion antivenom, spending nearly $50,000 on compute and another $150,000 on lab testing. The experiment generated 211 protein designs, but experts warn the results are premature and far from a viable medicine.